Psilocybin in Chronic Low Back Pain and Depression

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
This study seeks to provide insight on psilocybin\'s effects on mechanisms of chronic pain among patients with co-morbid chronic low back pain and depression (CLBP+D). Participants will receive either a single high-dose of psilocybin (25mg absolute dose) or methylphenidate (40mg absolute dose). Participants will be asked to complete assessments of pain, depressive symptoms, and more general questionnaires regarding the participants experiences during the experimental sessions and the associated enduring effects.
Epistemonikos ID: b5d553b3658b9a17a3384062af4a681c68a1b2c0
First added on: May 15, 2024